Headline
The latest stories from AHA Today.
Nearly 16 million people selected a 2023 health plan through the federally facilitated or state-based marketplaces Nov. 1 through Jan. 7, the Centers for Medicare & Medicaid Services reported.
The Department of Health and Human Services renewed the COVID-19 public health emergency declaration for another 90 days.
States that expanded Medicaid coverage to low-income adults in 2014 under the Affordable Care Act reduced postpartum hospitalizations for low-income people, according to a study reported yesterday in Health Affairs, which compared 2010-2017 data from four states that expanded Medicaid and four that…
As drug prices continue to rise, the 340B drug pricing program continues to help hospitals expand access to comprehensive health services, including lifesaving prescription drugs for those in need who may not be able to afford them, writes AHA President and CEO Rick Pollack in the Wall Street…
The Centers for Medicare & Medicaid Services today allocated 200 new Medicare-funded residency slots to 100 teaching hospitals in health professional shortage areas with the greatest need, as described in the inpatient prospective payment system final rule for fiscal year 2022.
The U.S. District Court for the District of Columbia today decided to allow the Department of Health and Human Services to propose an appropriate remedy for its past underpayments to hospitals participating in the 340B drug pricing program
Joseph Perras, M.D., president and CEO of Mt. Ascutney Hospital and Health Center, Dartmouth Health (Vermont), will serve as 2023 chair of the AHA Rural Health Services Committee. Sean Fadale, president and CEO of Nathan Littauer Hospital and Nursing Home (New York), is chair-elect. Philip Pandolph…
The Department of Labor has extended to Jan. 20 the deadline for nonprofit organizations, educational institutions and tribal organizations to apply for up to $6 million each to train current and former nurses to become nursing educators, and frontline health care workers to advance to nursing…
Evusheld may not prevent COVID-19 in immunocompromised individuals exposed to the XBB.1.5 omicron subvariant, because the treatment has failed to neutralize similar subvariants, the Food and Drug Administration announced Friday. While it awaits additional data to verify this, FDA recommends health…
The Health Resources and Services Administration today awarded nearly $60 million over five years to help 24 health care and educational organizations integrate mental health training into training for primary care clinicians, with a focus on preparing them to treat mental health needs in children…